Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Iofina plc (IOFNF)
London, GB
Iofina plc is an enterprise primarily focused on the procurement and fabrication of iodine, alongside its specialized chemical derivatives. The company also handles produced water and natural gas resources. Its operational footprint spans across both the United States and the United Kingdom. A diverse array of products is offered by Iofina, encompassing halogen compounds, sanitizers, electronic specialty gases, preservatives, heat stabilizers, and various intermediate chemicals. Beyond these, their offerings extend to solutions for animal well-being, mineral refinement, and scent management. These essential products cater to a broad spectrum of sectors, including the electronics and semiconductor industry, pharmaceuticals, food and beverage production, personal hygiene, paints and coatings, dairy processing, chemical manufacturing, gemology, wildlife management, and the nylon industry. Moreover, Iofina extends its expertise by supplying all-encompassing, fee-based solutions to external operators of brine streams, facilitating the efficient extraction of iodine. The company originated in 2005 and maintains its principal offices in London, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.59% | +8.47% | +77.78% | +77.78% | +106.45% | +76.11% | +114.61% | +60.00% | +276.47% | +146.15% | -62.57% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%+24.8% ★ Q4'25: +46.0% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+173.3% ★ Q4'25: +79.7% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.3% Q4'25: +16.7% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+13.1% ★ Q4'25: +18.5% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+13.1% ★ Q4'25: +41.7% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+0.4% Q4'25: 0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.55× ★ Q4'25: 0.19× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
20.33M
est: 20.60M (-1.3%)
|
22.49M
est: 20.90M (+7.6%)
|
20.83M
est: 20.80M (+0.1%)
|
23.96M
est: 25.00M (-4.2%)
|
29.25M
est: 29.50M (-0.9%)
|
29.69M
est: 29.80M (-0.4%)
|
39.04M
est: 36.70M (+6.4%)
|
42.20M
est: 42.20M (0.0%)
|
50.04M
est: 50.00M (+0.1%)
|
54.47M
est: 54.50M (-0.1%)
|
67.99M
est: 66.52M (+2.2%)
|
70.39M
70.39M – 70.39M
+5.8% YoY
|
90.25M
90.25M – 90.25M
+28.2% YoY
|
120.97M
120.97M – 120.97M
+34.0% YoY
|
| EBITDA |
491.7K
est: 4.01M (-87.7%)
|
367.0K
est: 4.07M (-91.0%)
|
-4.96M
est: 4.05M (-222.4%)
|
2.32M
est: 4.87M (-52.3%)
|
4.64M
est: 5.74M (-19.3%)
|
4.61M
est: 5.80M (-20.6%)
|
7.10M
est: 7.14M (-0.7%)
|
11.96M
est: 8.22M (+45.6%)
|
10.64M
est: 9.73M (+9.3%)
|
7.65M
est: 10.85M (-29.5%)
|
12.08M
est: 13.25M (-8.8%)
|
14.02M
14.02M – 14.02M
+5.8% YoY
|
17.98M
17.98M – 17.98M
+28.2% YoY
|
24.09M
24.09M – 24.09M
+34.0% YoY
|
| EBIT |
-1.56M
est: 3.06M (-150.8%)
|
-1.68M
est: 3.10M (-154.1%)
|
-7.04M
est: 3.09M (-327.8%)
|
409.6K
est: 3.71M (-89.0%)
|
3.03M
est: 4.38M (-30.9%)
|
2.93M
est: 4.42M (-33.9%)
|
5.39M
est: 5.45M (-1.0%)
|
10.17M
est: 6.27M (+62.3%)
|
8.59M
est: 7.42M (+15.8%)
|
5.07M
est: 8.44M (-40.0%)
|
8.88M
est: 10.30M (-13.8%)
|
10.90M
10.90M – 10.90M
+5.8% YoY
|
13.98M
13.98M – 13.98M
+28.2% YoY
|
18.74M
18.74M – 18.74M
+34.0% YoY
|
| Net Income |
-2.98M
est: -5.41M (+45.0%)
|
-3.66M
est: -6.38M (+42.5%)
|
-9.74M
est: -4.25M (-129.0%)
|
-1.14M
est: -2.51M (+54.5%)
|
552.4K
est: 1.76M (-68.6%)
|
1.28M
est: 13.69M (-90.7%)
|
9.19M
est: 4.50M (+104.2%)
|
7.87M
est: 7.24M (+8.7%)
|
6.56M
est: 6.85M (-4.1%)
|
2.92M
est: 2.98M (-2.1%)
|
8.04M
est: 6.40M (+25.8%)
|
7.75M
7.75M – 7.75M
+21.2% YoY
|
12.33M
12.33M – 12.33M
+59.0% YoY
|
18.58M
18.58M – 18.58M
+50.8% YoY
|
| SGA |
1.64M
est: 1.88M (-12.7%)
|
1.70M
est: 1.90M (-10.8%)
|
1.03M
est: 1.90M (-45.8%)
|
908.2K
est: 2.28M (-60.1%)
|
3.82M
est: 2.69M (+42.3%)
|
3.69M
est: 2.71M (+35.8%)
|
3.79M
est: 3.34M (+13.3%)
|
4.36M
est: 3.84M (+13.4%)
|
4.87M
est: 4.56M (+7.0%)
|
1.83M
est: 4.60M (-60.2%)
|
6.16M
est: 5.61M (+9.8%)
|
5.94M
5.94M – 5.94M
+5.8% YoY
|
7.62M
7.62M – 7.62M
+28.2% YoY
|
10.21M
10.21M – 10.21M
+34.0% YoY
|
| EPS |
-0.02
est: -0.03 (+15.7%)
|
-0.03
est: -0.03 (+11.9%)
|
-0.08
est: -0.02 (-251.2%)
|
-0.01
est: -0.01 (+29.9%)
|
0.00
est: 0.01 (-62.2%)
|
0.01
est: 0.07 (-90.4%)
|
0.05
est: 0.02 (+108.3%)
|
0.04
est: 0.04 (+10.8%)
|
0.03
est: 0.04 (-2.3%)
|
0.02
est: 0.02 (-1.1%)
|
0.04
est: 0.03 (+28.7%)
|
0.04
0.04 – 0.04
+21.2% YoY
|
0.06
0.06 – 0.06
+59.0% YoY
|
0.09
0.09 – 0.09
+50.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas Matthew Becker | Chief Executive Officer, President & Executive Director | 303.4K | — |
| Malcolm Thomas Lewin | Chief Financial Officer & Executive Director | 196.4K | male |
| Forest Dale Dorn | Chief Operating Officer of Iofina Resources Inc | — | male |
| Kurt Jones | Chief Operating Officer of Iofina Chemical Inc | — | male |
| Simon William Holden | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IOFNF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
